Global Personalized Cancer Vaccines Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Personalized Cancer Vaccines market report explains the definition, types, applications, major countries, and major players of the Personalized Cancer Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Genocea

    • Moderna Therapeutics

    • Personalis

    • Hoffmann-La Roche Ltd

    • Gritstone Oncology

    • Merck

    • Celldex

    • ISA Pharmaceuticals

    • BioNtech

    • Advaxis Inc

    • CureVac AG

    • Genetech

    By Type:

    • By Cancer Type

    • Lung Cancer

    • Breast Cancer

    • Colorectal Cancer

    • Leukemia

    • Prostate Cancer

    • Cervical Cancer

    • Glioblastoma

    • Others

    • By Mechanism of Action Type

    • Tumor-associated antigens (TAAs)

    • Tumor-specific antigens (TSAs)

    • Somatic Mutations in Cancer Pharmacogenomics

    • Pharmacogenomics towards Genomic Polymorphism

    By End-User:

    • Hospitals

    • Homecare

    • Specialty Clinics

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Personalized Cancer Vaccines Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Personalized Cancer Vaccines Outlook to 2028- Original Forecasts

    • 2.2 Personalized Cancer Vaccines Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Personalized Cancer Vaccines Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Personalized Cancer Vaccines Market- Recent Developments

    • 6.1 Personalized Cancer Vaccines Market News and Developments

    • 6.2 Personalized Cancer Vaccines Market Deals Landscape

    7 Personalized Cancer Vaccines Raw Materials and Cost Structure Analysis

    • 7.1 Personalized Cancer Vaccines Key Raw Materials

    • 7.2 Personalized Cancer Vaccines Price Trend of Key Raw Materials

    • 7.3 Personalized Cancer Vaccines Key Suppliers of Raw Materials

    • 7.4 Personalized Cancer Vaccines Market Concentration Rate of Raw Materials

    • 7.5 Personalized Cancer Vaccines Cost Structure Analysis

      • 7.5.1 Personalized Cancer Vaccines Raw Materials Analysis

      • 7.5.2 Personalized Cancer Vaccines Labor Cost Analysis

      • 7.5.3 Personalized Cancer Vaccines Manufacturing Expenses Analysis

    8 Global Personalized Cancer Vaccines Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Personalized Cancer Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Personalized Cancer Vaccines Export by Region (Top 10 Countries) (2017-2028)

    9 Global Personalized Cancer Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Personalized Cancer Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global By Cancer Type Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Lung Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Leukemia Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Prostate Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Cervical Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Glioblastoma Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global Others Consumption and Growth Rate (2017-2022)

      • 9.1.10 Global By Mechanism of Action Type Consumption and Growth Rate (2017-2022)

      • 9.1.11 Global Tumor-associated antigens (TAAs) Consumption and Growth Rate (2017-2022)

      • 9.1.12 Global Tumor-specific antigens (TSAs) Consumption and Growth Rate (2017-2022)

      • 9.1.13 Global Somatic Mutations in Cancer Pharmacogenomics Consumption and Growth Rate (2017-2022)

      • 9.1.14 Global Pharmacogenomics towards Genomic Polymorphism Consumption and Growth Rate (2017-2022)

    • 9.2 Global Personalized Cancer Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Homecare Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Specialty Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Personalized Cancer Vaccines Market Analysis and Outlook till 2022

    • 10.1 Global Personalized Cancer Vaccines Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.2.2 Canada Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.2.3 Mexico Personalized Cancer Vaccines Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.3.2 UK Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.3.3 Spain Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.3.4 Belgium Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.3.5 France Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.3.6 Italy Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.3.7 Denmark Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.3.8 Finland Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.3.9 Norway Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.3.10 Sweden Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.3.11 Poland Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.3.12 Russia Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.3.13 Turkey Personalized Cancer Vaccines Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.4.2 Japan Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.4.3 India Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.4.4 South Korea Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.4.5 Pakistan Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.4.6 Bangladesh Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.4.7 Indonesia Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.4.8 Thailand Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.4.9 Singapore Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.4.10 Malaysia Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.4.11 Philippines Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.4.12 Vietnam Personalized Cancer Vaccines Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.5.2 Colombia Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.5.3 Chile Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.5.4 Argentina Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.5.5 Venezuela Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.5.6 Peru Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.5.7 Puerto Rico Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.5.8 Ecuador Personalized Cancer Vaccines Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.6.2 Kuwait Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.6.3 Oman Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.6.4 Qatar Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Personalized Cancer Vaccines Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.7.2 South Africa Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.7.3 Egypt Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.7.4 Algeria Personalized Cancer Vaccines Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Personalized Cancer Vaccines Consumption (2017-2022)

      • 10.8.2 New Zealand Personalized Cancer Vaccines Consumption (2017-2022)

    11 Global Personalized Cancer Vaccines Competitive Analysis

    • 11.1 Genocea

      • 11.1.1 Genocea Company Details

      • 11.1.2 Genocea Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Genocea Personalized Cancer Vaccines Main Business and Markets Served

      • 11.1.4 Genocea Personalized Cancer Vaccines Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Moderna Therapeutics

      • 11.2.1 Moderna Therapeutics Company Details

      • 11.2.2 Moderna Therapeutics Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Moderna Therapeutics Personalized Cancer Vaccines Main Business and Markets Served

      • 11.2.4 Moderna Therapeutics Personalized Cancer Vaccines Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Personalis

      • 11.3.1 Personalis Company Details

      • 11.3.2 Personalis Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Personalis Personalized Cancer Vaccines Main Business and Markets Served

      • 11.3.4 Personalis Personalized Cancer Vaccines Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Hoffmann-La Roche Ltd

      • 11.4.1 Hoffmann-La Roche Ltd Company Details

      • 11.4.2 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Main Business and Markets Served

      • 11.4.4 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Gritstone Oncology

      • 11.5.1 Gritstone Oncology Company Details

      • 11.5.2 Gritstone Oncology Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Gritstone Oncology Personalized Cancer Vaccines Main Business and Markets Served

      • 11.5.4 Gritstone Oncology Personalized Cancer Vaccines Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Merck

      • 11.6.1 Merck Company Details

      • 11.6.2 Merck Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Merck Personalized Cancer Vaccines Main Business and Markets Served

      • 11.6.4 Merck Personalized Cancer Vaccines Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Celldex

      • 11.7.1 Celldex Company Details

      • 11.7.2 Celldex Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Celldex Personalized Cancer Vaccines Main Business and Markets Served

      • 11.7.4 Celldex Personalized Cancer Vaccines Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 ISA Pharmaceuticals

      • 11.8.1 ISA Pharmaceuticals Company Details

      • 11.8.2 ISA Pharmaceuticals Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 ISA Pharmaceuticals Personalized Cancer Vaccines Main Business and Markets Served

      • 11.8.4 ISA Pharmaceuticals Personalized Cancer Vaccines Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 BioNtech

      • 11.9.1 BioNtech Company Details

      • 11.9.2 BioNtech Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 BioNtech Personalized Cancer Vaccines Main Business and Markets Served

      • 11.9.4 BioNtech Personalized Cancer Vaccines Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Advaxis Inc

      • 11.10.1 Advaxis Inc Company Details

      • 11.10.2 Advaxis Inc Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Advaxis Inc Personalized Cancer Vaccines Main Business and Markets Served

      • 11.10.4 Advaxis Inc Personalized Cancer Vaccines Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 CureVac AG

      • 11.11.1 CureVac AG Company Details

      • 11.11.2 CureVac AG Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 CureVac AG Personalized Cancer Vaccines Main Business and Markets Served

      • 11.11.4 CureVac AG Personalized Cancer Vaccines Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Genetech

      • 11.12.1 Genetech Company Details

      • 11.12.2 Genetech Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Genetech Personalized Cancer Vaccines Main Business and Markets Served

      • 11.12.4 Genetech Personalized Cancer Vaccines Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    12 Global Personalized Cancer Vaccines Market Outlook by Types and Applications to 2028

    • 12.1 Global Personalized Cancer Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global By Cancer Type Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Leukemia Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Cervical Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.8 Global Glioblastoma Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.9 Global Others Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.10 Global By Mechanism of Action Type Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.11 Global Tumor-associated antigens (TAAs) Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.12 Global Tumor-specific antigens (TSAs) Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.13 Global Somatic Mutations in Cancer Pharmacogenomics Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.14 Global Pharmacogenomics towards Genomic Polymorphism Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Personalized Cancer Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Homecare Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Personalized Cancer Vaccines Market Analysis and Outlook to 2028

    • 13.1 Global Personalized Cancer Vaccines Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.2.2 Canada Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Personalized Cancer Vaccines Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.3.2 UK Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.3.3 Spain Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.3.5 France Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.3.6 Italy Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.3.8 Finland Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.3.9 Norway Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.3.11 Poland Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.3.12 Russia Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Personalized Cancer Vaccines Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.4.2 Japan Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.4.3 India Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Personalized Cancer Vaccines Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.5.3 Chile Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.5.6 Peru Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Personalized Cancer Vaccines Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.6.3 Oman Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Personalized Cancer Vaccines Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Personalized Cancer Vaccines Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Personalized Cancer Vaccines Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Personalized Cancer Vaccines Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Personalized Cancer Vaccines

    • Figure of Personalized Cancer Vaccines Picture

    • Table Global Personalized Cancer Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Personalized Cancer Vaccines Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global By Cancer Type Consumption and Growth Rate (2017-2022)

    • Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Leukemia Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Cervical Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Glioblastoma Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global By Mechanism of Action Type Consumption and Growth Rate (2017-2022)

    • Figure Global Tumor-associated antigens (TAAs) Consumption and Growth Rate (2017-2022)

    • Figure Global Tumor-specific antigens (TSAs) Consumption and Growth Rate (2017-2022)

    • Figure Global Somatic Mutations in Cancer Pharmacogenomics Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacogenomics towards Genomic Polymorphism Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Homecare Consumption and Growth Rate (2017-2022)

    • Figure Global Specialty Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Personalized Cancer Vaccines Consumption by Country (2017-2022)

    • Table North America Personalized Cancer Vaccines Consumption by Country (2017-2022)

    • Figure United States Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Canada Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Mexico Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Personalized Cancer Vaccines Consumption by Country (2017-2022)

    • Figure Germany Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure UK Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Spain Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Belgium Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure France Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Italy Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Denmark Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Finland Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Norway Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Sweden Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Poland Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Russia Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Turkey Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Table APAC Personalized Cancer Vaccines Consumption by Country (2017-2022)

    • Figure China Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Thailand Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Singapore Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Philippines Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Table South America Personalized Cancer Vaccines Consumption by Country (2017-2022)

    • Figure Brazil Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Colombia Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Chile Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Argentina Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Peru Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Table GCC Personalized Cancer Vaccines Consumption by Country (2017-2022)

    • Figure Bahrain Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Oman Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Qatar Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Table Africa Personalized Cancer Vaccines Consumption by Country (2017-2022)

    • Figure Nigeria Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Africa Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Egypt Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Algeria Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Table Oceania Personalized Cancer Vaccines Consumption by Country (2017-2022)

    • Figure Australia Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Table Genocea Company Details

    • Table Genocea Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genocea Personalized Cancer Vaccines Main Business and Markets Served

    • Table Genocea Personalized Cancer Vaccines Product Portfolio

    • Table Moderna Therapeutics Company Details

    • Table Moderna Therapeutics Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Moderna Therapeutics Personalized Cancer Vaccines Main Business and Markets Served

    • Table Moderna Therapeutics Personalized Cancer Vaccines Product Portfolio

    • Table Personalis Company Details

    • Table Personalis Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Personalis Personalized Cancer Vaccines Main Business and Markets Served

    • Table Personalis Personalized Cancer Vaccines Product Portfolio

    • Table Hoffmann-La Roche Ltd Company Details

    • Table Hoffmann-La Roche Ltd Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hoffmann-La Roche Ltd Personalized Cancer Vaccines Main Business and Markets Served

    • Table Hoffmann-La Roche Ltd Personalized Cancer Vaccines Product Portfolio

    • Table Gritstone Oncology Company Details

    • Table Gritstone Oncology Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gritstone Oncology Personalized Cancer Vaccines Main Business and Markets Served

    • Table Gritstone Oncology Personalized Cancer Vaccines Product Portfolio

    • Table Merck Company Details

    • Table Merck Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Personalized Cancer Vaccines Main Business and Markets Served

    • Table Merck Personalized Cancer Vaccines Product Portfolio

    • Table Celldex Company Details

    • Table Celldex Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celldex Personalized Cancer Vaccines Main Business and Markets Served

    • Table Celldex Personalized Cancer Vaccines Product Portfolio

    • Table ISA Pharmaceuticals Company Details

    • Table ISA Pharmaceuticals Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table ISA Pharmaceuticals Personalized Cancer Vaccines Main Business and Markets Served

    • Table ISA Pharmaceuticals Personalized Cancer Vaccines Product Portfolio

    • Table BioNtech Company Details

    • Table BioNtech Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioNtech Personalized Cancer Vaccines Main Business and Markets Served

    • Table BioNtech Personalized Cancer Vaccines Product Portfolio

    • Table Advaxis Inc Company Details

    • Table Advaxis Inc Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Advaxis Inc Personalized Cancer Vaccines Main Business and Markets Served

    • Table Advaxis Inc Personalized Cancer Vaccines Product Portfolio

    • Table CureVac AG Company Details

    • Table CureVac AG Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table CureVac AG Personalized Cancer Vaccines Main Business and Markets Served

    • Table CureVac AG Personalized Cancer Vaccines Product Portfolio

    • Table Genetech Company Details

    • Table Genetech Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genetech Personalized Cancer Vaccines Main Business and Markets Served

    • Table Genetech Personalized Cancer Vaccines Product Portfolio

    • Figure Global By Cancer Type Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Leukemia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cervical Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Glioblastoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global By Mechanism of Action Type Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tumor-associated antigens (TAAs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tumor-specific antigens (TSAs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Somatic Mutations in Cancer Pharmacogenomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacogenomics towards Genomic Polymorphism Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Homecare Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Personalized Cancer Vaccines Consumption Forecast by Country (2022-2028)

    • Table North America Personalized Cancer Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Personalized Cancer Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Germany Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Personalized Cancer Vaccines Consumption Forecast by Country (2022-2028)

    • Figure China Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Personalized Cancer Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Brazil Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Personalized Cancer Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Personalized Cancer Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Personalized Cancer Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Australia Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.